Detection of Early Idiopathic Pulmonary Fibrosis
NCT03457935 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2025-12-29
Summary
The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.
Conditions
Interventions
- OTHER
-
blood samples
Blood samples
Sponsors & Collaborators
- collaborator INDUSTRY
-
Temple University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-10
- Primary Completion
- 2025-12-31
- Completion
- 2026-08-30
Countries
- United States
Study Locations
More Related Trials
-
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
NCT00540475 ·Status: COMPLETED
-
The Genetics of Pulmonary Fibrosis
NCT03478553 ·Status: RECRUITING
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Dose Reduction and Discontinuation With Anti-Fibrotic Medications
NCT05779007 ·Status: COMPLETED
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
NCT04362644 ·Status: RECRUITING ·Phase: PHASE1
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
NCT03958071 ·Status: COMPLETED
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
NCT01718990 ·Status: COMPLETED
-
Mechanisms of Familial Pulmonary Fibrosis
NCT03437486 ·Status: RECRUITING
-
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
NCT00258570 ·Status: RECRUITING
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
NCT02772549 ·Status: ACTIVE_NOT_RECRUITING
-
Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
NCT00005317 ·Status: COMPLETED
-
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
NCT01874223 ·Status: COMPLETED
-
Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
NCT03183570 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
NCT01177618 ·Status: RECRUITING
-
A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device
NCT05670587 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease
NCT02734368 ·Status: TERMINATED
-
Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis
NCT03744598 ·Status: TERMINATED
-
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
NCT02187393 ·Status: WITHDRAWN
-
Disease-syndrome Characteristics of IPF
NCT07178392 ·Status: NOT_YET_RECRUITING
-
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02719184 ·Status: COMPLETED